Onesource Specialty Pharma Limited has informed the Exchange regarding 'The Management Allottment of 30,000 Equity shares of the Company under OneSource Specialty Pharma Limited: Employee Stock Option Scheme, 2021, to the eligible employees'.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
OneSource Specialty Pharma Limited has allotted 30,000 equity shares to eligible employees under the company's Employee Stock Option Plan 2021, upon exercise of vested options. The shares have a face value of INR 1 each and were issued at an exercise price of INR 278 per share (premium of INR 277). As a result, the company's paid-up equity share capital has increased from INR 11,44,36,021 to INR 11,44,66,021, taking the total number of equity shares to 11,44,66,021. The newly issued shares will rank equally with existing equity shares in all respects, and there is no lock-in period applicable.
This is a routine ESOP allotment with a very small dilution (30,000 shares out of ~11.44 crore), so it is unlikely to have any meaningful impact on the stock price or shareholder value.